Cerebras targets up to $4 billion in IPO with $40 billion valuation - Bloomberg

United Therapeutics CFO James Edgemond sells $5.7m in stock

Investing.com · News 6m ago

United Therapeutics chairperson & CEO Rothblatt sells $5.44m shares

Investing.com · News 6m ago

Uranium Royalty closes $40M private placement with UEC

Investing.com · News 6m ago

Exodus acquires Monavate and Baanx for $76.3 million

Investing.com · News 6m ago

Form 13G ETHOS TECHNOLOGIES INC. For: 1 May

Investing.com · News 6m ago

Gold prices marginally lower in choppy session after posting a decline in April

Investing.com · Investing_news 7m ago

Berkshire Hathaway’s shopping extravaganza draws lighter crowds as spotlight shifts to Greg Abel

CNBC · Economy 11m ago

Tech, Media & Telecom Roundup: Market Talk

Dow Jones · Markets 12m ago

Japanese yen weakens a day after reports of currency intervention, dollar rises

Investing.com · Investing_news 12m ago

Barclays raises HF Sinclair stock price target to $71 on supply outlook

Investing.com · News 15m ago